FDA Commissioner Dr. Marty Makary is resigning after just over a year, bowing to mounting pressure from pharmaceutical executives, vaping lobbyists, and conservative activists. The departure follows a turbulent tenure characterized by mass staff exoduses, controversial vaccine restrictions, and clashes over political interference in scientific regulations.
A significant catalyst for Makary's exit came from the vaping industry. Vaping executives directly lobbied President Trump, arguing that Makary was deliberately blocking the approval of new flavored e-cigarettes, which they view as critical to their market survival.
In a desperate bid to ease tensions last week, the FDA abruptly reversed course. The agency authorized the first fruit-flavored vaping products and loosened marketing guidelines for major manufacturers. However, this last-minute concession was not enough to secure Makary’s position.
Kyle Diamantas will assume the role of acting commissioner, inheriting an agency grappling with severe internal dysfunction. During Makary’s tenure, virtually all senior career officials resigned, retired, or were forced out.
Makary struggled to balance the administration's demands to cut red tape with Health Secretary Robert F. Kennedy Jr.’s intense scrutiny of vaccines and food additives. This friction was most evident in the FDA’s drug center, which cycled through six different directors in a single year amid clashes over review processes.
Much of the agency's instability was driven by Makary’s handpicked deputy, Dr. Vinay Prasad, who was pushed out twice after severely disrupting pharmaceutical predictability. Prasad's controversial actions included:
- Arbitrary Restrictions: Repeatedly overruling career scientific staff to restrict eligibility for new COVID-19 shots.
- The Moderna Conflict: Initially refusing to review Moderna’s mRNA flu shot, forcing an agency reversal only after the company threatened formal challenges and White House intervention.
- Unsubstantiated Claims: Attempting to overhaul vaccine approvals based on an internal memo claiming COVID shots were linked to child deaths—a claim made without published evidence that drew scathing condemnation from a dozen former FDA commissioners.
Beyond vaccines and vaping, Makary faced political backlash from anti-abortion groups who accused him of slow-walking an internal review of the abortion pill mifepristone.
While Makary aggressively promoted initiatives to streamline drug reviews using artificial intelligence, his legacy remains precarious. Because most of his programs bypassed the formal federal rulemaking process, they lack permanent regulatory standing. With his departure, these initiatives face an uncertain future and potential legal challenges from Congress.
- News source: Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Digital Content Creator & Vape Industry Analyst
Jake Miller is a prominent voice in the American vaping community, known for his transparent, tech-focused approach to harm reduction and hardware innovation. With over six years of experience in the industry, Tyler transitioned from a hobbyist to a full-time content creator, building a loyal following through his unfiltered reviews and deep-dive technical tutorials.